{
  "disease_name": "Pearson syndrome",
  "orpha_code": "699",
  "drugs": [
    {
      "name": "Encaleret sulfate",
      "substance_url": "/en/drug/substance/627727?name=699&mode=orpha&region=&status=all",
      "substance_id": "627727",
      "regulatory_url": "/en/drug/regulatory/627728?name=699&mode=orpha&region=",
      "regulatory_id": "627728",
      "orpha_substance_code": "ORPHA:208593",
      "details": [
        "Encaleret sulfate(Medicinal product                        - 15/10/2021)Disease(s) concernedORPHA:181405 Rare hypoparathyroidismORPHA:208593 Genetic hypoparathyroidism",
        "Encaleret sulfate(Medicinal product                        - 15/10/2021)",
        "(Medicinal product                        - 15/10/2021)",
        "Disease(s) concernedORPHA:181405 Rare hypoparathyroidismORPHA:208593 Genetic hypoparathyroidism",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627727?name=699&mode=orpha&region=&status=all",
          "text": "Encaleret sulfate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/181405",
          "text": "ORPHA:181405 Rare hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/208593",
          "text": "ORPHA:208593 Genetic hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627728?name=699&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Palopegteriparatide",
      "substance_url": "/en/drug/substance/604906?name=699&mode=orpha&region=&status=all",
      "substance_id": "604906",
      "regulatory_url": "/en/drug/regulatory/604907?name=699&mode=orpha&region=",
      "regulatory_id": "604907",
      "orpha_substance_code": "ORPHA:208593",
      "details": [
        "Palopegteriparatide(Medicinal product                        - 19/10/2020)Disease(s) concernedORPHA:2238 Familial isolated hypoparathyroidismORPHA:181405 Rare hypoparathyroidismORPHA:208593 Genetic hypoparathyroidism",
        "Palopegteriparatide(Medicinal product                        - 19/10/2020)",
        "(Medicinal product                        - 19/10/2020)",
        "Disease(s) concernedORPHA:2238 Familial isolated hypoparathyroidismORPHA:181405 Rare hypoparathyroidismORPHA:208593 Genetic hypoparathyroidism",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604906?name=699&mode=orpha&region=&status=all",
          "text": "Palopegteriparatide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2238",
          "text": "ORPHA:2238 Familial isolated hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/181405",
          "text": "ORPHA:181405 Rare hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/208593",
          "text": "ORPHA:208593 Genetic hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604907?name=699&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human parathyroid hormone",
      "substance_url": "/en/drug/substance/367963?name=699&mode=orpha&region=&status=all",
      "substance_id": "367963",
      "regulatory_url": "/en/drug/regulatory/377573?name=699&mode=orpha&region=",
      "regulatory_id": "377573",
      "orpha_substance_code": "ORPHA:181402",
      "details": [
        "Recombinant human parathyroid hormone(Medicinal product                        - 16/01/2014)Disease(s) concernedORPHA:2238 Familial isolated hypoparathyroidismORPHA:3453 Autoimmune polyendocrinopathy type 1ORPHA:181402 Syndrome with hypoparathyroidism",
        "Recombinant human parathyroid hormone(Medicinal product                        - 16/01/2014)",
        "(Medicinal product                        - 16/01/2014)",
        "Disease(s) concernedORPHA:2238 Familial isolated hypoparathyroidismORPHA:3453 Autoimmune polyendocrinopathy type 1ORPHA:181402 Syndrome with hypoparathyroidism",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/367963?name=699&mode=orpha&region=&status=all",
          "text": "Recombinant human parathyroid hormone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2238",
          "text": "ORPHA:2238 Familial isolated hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/3453",
          "text": "ORPHA:3453 Autoimmune polyendocrinopathy type 1",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/181402",
          "text": "ORPHA:181402 Syndrome with hypoparathyroidism",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/377573?name=699&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "with hypoparathyroidism\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate",
      "substance_url": "/en/drug/substance/646586?name=699&mode=orpha&region=&status=all",
      "substance_id": "646586",
      "regulatory_url": "/en/drug/regulatory/646683?name=699&mode=orpha&region=",
      "regulatory_id": "646683",
      "orpha_substance_code": "ORPHA:68380",
      "details": [
        "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate(Medicinal product                        - 14/04/2023)Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate(Medicinal product                        - 14/04/2023)",
        "(Medicinal product                        - 14/04/2023)",
        "Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/646586?name=699&mode=orpha&region=&status=all",
          "text": "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/68380",
          "text": "ORPHA:68380 Mitochondrial disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/646683?name=699&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Zagociguat",
      "substance_url": "/en/drug/substance/644348?name=699&mode=orpha&region=&status=all",
      "substance_id": "644348",
      "regulatory_url": "/en/drug/regulatory/644353?name=699&mode=orpha&region=",
      "regulatory_id": "644353",
      "orpha_substance_code": "ORPHA:68380",
      "details": [
        "Zagociguat(Medicinal product                        - 23/03/2023)Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "Zagociguat(Medicinal product                        - 23/03/2023)",
        "(Medicinal product                        - 23/03/2023)",
        "Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/644348?name=699&mode=orpha&region=&status=all",
          "text": "Zagociguat",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/68380",
          "text": "ORPHA:68380 Mitochondrial disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/644353?name=699&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Vatiquinone",
      "substance_url": "/en/drug/substance/285822?name=699&mode=orpha&region=&status=all",
      "substance_id": "285822",
      "regulatory_url": "/en/drug/regulatory/299940?name=699&mode=orpha&region=",
      "regulatory_id": "299940",
      "orpha_substance_code": "ORPHA:254827",
      "details": [
        "Vatiquinone(Medicinal product                        - 21/12/2010)Disease(s) concernedORPHA:223713 Mitochondrial oxidative phosphorylation disorderORPHA:254827 Mitochondrial membrane transport disorder",
        "Vatiquinone(Medicinal product                        - 21/12/2010)",
        "(Medicinal product                        - 21/12/2010)",
        "Disease(s) concernedORPHA:223713 Mitochondrial oxidative phosphorylation disorderORPHA:254827 Mitochondrial membrane transport disorder",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/285822?name=699&mode=orpha&region=&status=all",
          "text": "Vatiquinone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/223713",
          "text": "ORPHA:223713 Mitochondrial oxidative phosphorylation disorder",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/254827",
          "text": "ORPHA:254827 Mitochondrial membrane transport disorder",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/299940?name=699&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "ORPHA:254827 Mitochondrial membrane transport disorder\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:02:59.573590",
  "run_number": 1,
  "total_drugs_found": 6,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Pearson+syndrome&orphaCode=699&name=699&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Pearson syndrome",
    "orphaCode": "699",
    "name": "699",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}